Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-22 Sale | 2022-09-26 4:30 pm | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner | 211,380 | $41.17 | $8,702,113 | 34,027,253 (Indirect) | View |
| 2022-09-20 Sale | 2022-09-22 4:31 pm | Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Skyeline Management Ltd Avara Management Ltd Director 10% Owner | 523,842 | $41.07 | $21,516,554 | 11,848,633 (Indirect) | View |
| 2022-09-20 Sale | 2022-09-22 4:30 pm | Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner | 267,815 | $41.02 | $10,985,798 | 21,426,170 (Indirect) | View |
| 2022-09-16 Sale | 2022-09-20 4:30 pm | Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Director 10% Owner | 387,171 | $41.59 | $16,101,817 | 34,762,475 (Indirect) | View |
| 2022-09-16 Sale | 2022-09-20 4:30 pm | Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner | 387,171 | $41.59 | $16,101,934 | 21,693,985 (Indirect) | View |
| 2022-09-14 Sale | 2022-09-16 5:09 pm | Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. MGG Strategic SICAF SIF S.A. - MGG Strategic Director 10% Owner | 345,014 | $42.38 | $14,622,925 | 35,149,646 (Indirect) | View |
| 2022-09-14 Sale | 2022-09-16 5:05 pm | Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. GG 1978 SICAF SIF S.A. - GG Strategic 10% Owner | 345,014 | $42.38 | $14,623,052 | 22,081,156 (Indirect) | View |
| 2022-09-14 Sale | 2022-09-15 7:56 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 100,000 | $42.3 | $4,230,387 | 376,899 (Indirect Direct) | View |
| 2022-09-07 Sale | 2022-09-09 4:18 pm | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner | 499,500 | $42.7 | $21,327,337 | 35,494,660 (Indirect) | View |
| 2022-09-07 Sale | 2022-09-09 4:17 pm | Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner | 498,006 | $42.7 | $21,262,534 | 22,426,170 (Indirect) | View |
| 2022-08-25 Sale | 2022-08-29 5:41 pm | Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner | 1,994 | $44 | $87,736 | 22,924,176 (Indirect) | View |
| 2022-08-25 Sale | 2022-08-29 5:40 pm | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner | 500 | $44 | $22,000 | 35,994,160 (Indirect) | View |
| 2022-08-09 Sale | 2022-08-11 5:07 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 45,000 | $43.73 | $1,967,823 | 476,899 (Indirect Direct) | View |
| 2022-08-09 Sale | 2022-08-11 5:02 pm | Royalty Pharma plc | RPRX | Lloyd George W. VP | 20,854 | $43.92 | $915,909 | 1,357,945 (Indirect Direct) | View |
| 2022-08-01 Sale | 2022-08-03 7:12 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 30,000 | $43.19 | $1,295,727 | 1,020,390 (Indirect Direct) | View |
| 2022-07-28 Sale | 2022-08-01 5:01 pm | Royalty Pharma plc | RPRX | Lloyd George W. VP | 4,046 | $43.97 | $177,893 | 1,378,799 (Indirect Direct) | View |
| 2022-07-25 Sale | 2022-07-27 6:20 pm | Royalty Pharma plc | RPRX | Lloyd George W. VP | 75,100 | $43.25 | $3,248,199 | 1,002,845 (Indirect Direct) | View |
| 2022-07-25 Sale | 2022-07-27 6:17 pm | Royalty Pharma plc | RPRX | Urist Marshall VP | 23,334 | $43.18 | $1,007,446 | 19,020 (Indirect Direct) | View |
| 2022-06-29 Sale | 2022-06-29 6:02 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 30,000 | $42.17 | $1,265,238 | 521,899 (Indirect Direct) | View |
| 2022-06-24 Sale | 2022-06-24 5:19 pm | Royalty Pharma plc | RPRX | Urist Marshall VP | 23,333 | $43.19 | $1,007,694 | 42,354 (Indirect Direct) | View |
| 2022-06-08 Sale | 2022-06-10 5:13 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 100,000 | $41.56 | $4,155,900 | 945,830 (Indirect) | View |
| 2022-05-27 Sale | 2022-05-31 5:23 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 75,000 | $41.08 | $3,081,008 | 1,045,830 (Indirect) | View |
| 2022-05-26 Sale | 2022-05-31 5:19 pm | Royalty Pharma plc | RPRX | Lloyd George W. VP | 100,000 | $40.29 | $4,029,091 | 1,446,831 (Indirect Direct) | View |
| 2022-05-23 Sale | 2022-05-25 5:10 pm | Royalty Pharma plc | RPRX | Lloyd George W. VP | 100,000 | $40.27 | $4,026,770 | 1,546,831 (Indirect Direct) | View |
| 2022-05-19 Sale | 2022-05-23 4:57 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 75,000 | $40.44 | $3,033,128 | 1,120,830 (Indirect) | View |
| 2022-05-19 Sale | 2022-05-23 4:55 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 150,000 | $39.42 | $5,913,306 | 551,899 (Indirect Direct) | View |
| 2022-05-16 Sale | 2022-05-16 7:14 pm | Royalty Pharma plc | RPRX | Urist Marshall VP | 23,333 | $39.85 | $929,836 | 65,687 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-08 Option Award | 2022-07-11 7:02 pm | N/A N/A | Royalty Pharma plc | RPRX | HODGSON DAVID C Director | 2,346 | $0 | 8,674 (Direct) | View |
| 2022-06-30 Option Award | 2022-06-30 06:55 am | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 903 | $41.52 | 31,925 (Direct) | View |
| 2022-06-30 Option Award | 2022-06-30 06:51 am | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 903 | $41.52 | 84,331 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-24 4:59 pm | N/A N/A | Royalty Pharma plc | RPRX | Norden Gregory Director | 6,328 | $0 | 56,698 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-24 4:59 pm | N/A N/A | Royalty Pharma plc | RPRX | Engelbert Catherine M. Director | 6,328 | $0 | 25,464 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-24 4:57 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 6,328 | $0 | 31,022 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-24 4:57 pm | N/A N/A | Royalty Pharma plc | RPRX | LOVE TED W Director | 6,328 | $0 | 29,194 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-24 4:55 pm | N/A N/A | Royalty Pharma plc | RPRX | DESOUZA ERROL B Director | 6,328 | $0 | 56,698 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-24 4:53 pm | N/A N/A | Royalty Pharma plc | RPRX | HODGSON DAVID C Director | 6,328 | $0 | 6,328 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-24 4:49 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 6,328 | $0 | 83,428 (Direct) | View |
| 2022-05-11 Conversion | 2022-05-11 5:20 pm | N/A N/A | Royalty Pharma plc | RPRX | Urist Marshall VP | 77,000 | $0 | 294,614 (Direct) | View |
| 2020-06-16 Other | 2022-04-15 6:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 917,322 | $0 | 36,641,176 (Indirect) | View |
| 2020-06-16 Conversion | 2022-04-15 6:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 1,198,821 | $0 | 36,641,176 (Indirect) | View |